Mid-term effects of SARS-CoV-2 infection on cardiovascular outcomes

Arévalos, Victor; Ortega-Paz, Luis; Brugaletta, Salvatore

doi:10.1016/j.medcle.2021.05.008

array:23 ["pii" => "S2387020621006720" "issn" => "23870206" "doi" => "10.1016/j.medcle.2021.05.008" "estado" => "S300" "fechaPublicacion" => "2022-01-07" "aid" => "5705" "copyright" => "Elsevier España, S.L.U.. All rights reserved" "copyrightAnyo" => "2021" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Med Clin. 2022;158:41-2" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "itemSiguiente" => array:19 [ "pii" => "S2387020621006823" "issn" => "23870206" "doi" => "10.1016/j.medcle.2020.12.037" "estado" => "S300" "fechaPublicacion" => "2022-01-07" "aid" => "5593" "copyright" => "Elsevier España, S.L.U." "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Med Clin. 2022;158:42-3" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "Letter to the Editor" "titulo" => "Belimumab in refractory systemic lupus erythematosus pleural effusion" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "42" "paginaFinal" => "43" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Utilidad de belimumab en derrame pleural secundario a lupus eritematoso sistémico refractario" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Vicenç Torrente-Segarra, Maria Bonet" "autores" => array:2 [ 0 => array:2 [ "nombre" => "Vicenç" "apellidos" => "Torrente-Segarra" ] 1 => array:2 [ "nombre" => "Maria" "apellidos" => "Bonet" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S0025775321000853" "doi" => "10.1016/j.medcli.2020.12.036" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775321000853?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020621006823?idApp=UINPBA00004N" "url" => "/23870206/0000015800000001/v2_202201200752/S2387020621006823/v2_202201200752/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S2387020621006689" "issn" => "23870206" "doi" => "10.1016/j.medcle.2021.03.024" "estado" => "S300" "fechaPublicacion" => "2022-01-07" "aid" => "5667" "copyright" => "Elsevier España, S.L.U." "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Med Clin. 2022;158:40-1" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "Letter to the Editor" "titulo" => "Mediastinal Escherichia coli abscess during Fournier’s gangrene" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "40" "paginaFinal" => "41" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Absceso mediastínico por Escherichia coli en el curso de una gangrena de Fournier" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1601 "Ancho" => 1207 "Tamanyo" => 217522 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0005" "detalle" => "Fig. " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "Chest and abdomen CT. An abscess in the right posterior mediastinum (A) and inflammatory changes with air bubbles adjacent to the corpora cavernosa of the penis are observed, compatible with Fournier’s gangrene (B)." ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "José López-Fernández, Gabriel García Plaza, Ismael Antón Fernández" "autores" => array:3 [ 0 => array:2 [ "nombre" => "José" "apellidos" => "López-Fernández" ] 1 => array:2 [ "nombre" => "Gabriel" "apellidos" => "García Plaza" ] 2 => array:2 [ "nombre" => "Ismael Antón" "apellidos" => "Fernández" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0025775321002311" "doi" => "10.1016/j.medcli.2021.03.018" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775321002311?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020621006689?idApp=UINPBA00004N" "url" => "/23870206/0000015800000001/v2_202201200752/S2387020621006689/v2_202201200752/en/main.assets" ] "en" => array:16 [ "idiomaDefecto" => true "cabecera" => "Scientific letter" "titulo" => "Mid-term effects of SARS-CoV-2 infection on cardiovascular outcomes" "tieneTextoCompleto" => true "saludo" => "Dear Editor:" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "41" "paginaFinal" => "42" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Victor Arévalos, Luis Ortega-Paz, Salvatore Brugaletta" "autores" => array:3 [ 0 => array:3 [ "nombre" => "Victor" "apellidos" => "Arévalos" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "1" "identificador" => "fn1" ] ] ] 1 => array:3 [ "nombre" => "Luis" "apellidos" => "Ortega-Paz" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "1" "identificador" => "fn1" ] ] ] 2 => array:4 [ "nombre" => "Salvatore" "apellidos" => "Brugaletta" "email" => array:1 [ 0 => "sabrugaletta@gmail.com" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "*" "identificador" => "cor0005" ] ] ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Clinic Cardiovascular Institute, Department of Cardiology, Hospital Clinic, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain" "identificador" => "aff0005" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Efectos cardiovasculares a medio plazo de la infección por SARS-CoV-2" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2258 "Ancho" => 1500 "Tamanyo" => 179042 ] ] "descripcion" => array:1 [ "en" => "All-cause death and cardiovascular outcomes at six months follow-up in patients with or without COVID-19. (A) All-cause death time-to-event curve. (B) Six months follow-up cardiovascular outcomes. ACS, acute coronary syndrome; CV, cardiovascular; HFH, heart failure hospitalization; PE, pulmonary embolism." ] ] ] "textoCompleto" => "Coronavirus disease 2019 (COVID-19) has become the most important public health issue worldwide due to its rapid spread, morbidity, and mortality. Although its main target is the respiratory system, a significant proportion of COVID-19 patients exhibits myocardial injury, which is associated with a worse in-hospital prognosis.<a class="elsevierStyleCrossRefs" href="#bib0030">1–3</a> The pathophysiological mechanisms related to cardiovascular affectation are not entirely understood but may be related to intense endothelial damage, inflammation, thrombosis, and coagulopathy.<a class="elsevierStyleCrossRef" href="#bib0045">4</a> However, it is unknown if COVID-19 may affect the mid and long-term cardiovascular outcomes. We aim to describe the cardiovascular outcomes at six months following COVID-19 diagnosis.This is a single-center, retrospective registry of all consecutive hospitalized patients who underwent a real-time reverse transcriptase-polymerase chain reaction (RT-PCR) for SARS-CoV-2 from March 1 to April 19, 2020, at the University Hospital Hospital Clínic, Barcelona, Spain. The study was approved by the Ethics Committee and adhered to the principles outlined in Helsinki's Declaration.All information was obtained from electronic records (medical history and national social security database). Patients were divided into two groups according to the RT-PCR result to have a comparator arm. Rates of all-cause death and cardiovascular outcomes (cardiovascular death, acute coronary syndrome [ACS], stroke, heart failure hospitalization [HFH], and pulmonary embolism [PE]) were evaluated at 6-month follow-up and compared between groups. Endpoints were defined according to the Academic Research Consortium-2.<a class="elsevierStyleCrossRef" href="#bib0050">5</a> A Cox proportional hazards model along with a Wald test was used for comparison of outcomes. A crude analysis was performed for all endpoints, and adjusted analysis was performed only for all-cause death. Kaplan–Meier curves were used to derive the event rates at follow-up and to plot time-to-event curves. Patients not eligible for six-month follow-up were considered at risk until the date of last follow-up, at which point they were censored. A two-side p-value <0.05 was considered statistically significant. All data were processed using the Statistical Package for Social Sciences, version 25.0 (SPSS Inc., Chicago, IL, USA).A total of 865 individuals were included in the study, divided into 620 with COVID-19 and 245 without COVID-19. Patients with COVID-19 were older (59±18.6 years vs. 45±18.5 years, p<0.001), more frequently male (333 [53.7%] vs. 112 [45.7%], p=0.034), with higher body mass index (BMI) (27.5±5.0 vs. 24.2±5.0, p<0.001) compared with patients without. Furthermore, patients with COVID-19 had higher rates of hypertension (237 [38.2%] vs. 43 [17.6%], p<0.001), diabetes mellitus [94 (15.2%) vs. 6 (2.4%), p<0.001], and hypercholesterolemia [161 (26%) vs. 23 (9.4%), p<0.001] as compared to non-COVID-9 counterparts.Patients with COVID-19 had a higher risk of all-cause death compared to those without (15.6% [97/620] vs. 4.1% [10/245], adjusted HR: 2.82, [95% CI: 1.13–7.75], p=0.026) (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>A). Of note, this difference was driven by a higher risk of in-hospital all-cause death (13.9% vs. 1.6%, un-adjusted HR: 9.10 [95% CI 3.34–24.80], p=0.001), with no differences in post-discharge risk of all-cause death between patients with or without COVID-19 (2.1% [11/534] vs. 2.5% [6/241], un-adjusted HR: 0.85 [95% CI 0.31–2.28], p=0.739). Furthermore, at 6-month follow-up, cardiovascular death and PE rates were higher in COVID-19 patients than those without. Nevertheless, these differences were due to a higher rate of in-hospital cardiovascular death (2.3% vs. 0%, p=0.018) and PE (3.4% vs. 0%; p=0.001), without differences in the post-discharge follow-up. The in-hospital ACS rate was higher in patients with COVID-19 than those without (3.4% vs. 0.4%, p=0.008). At 6-month, there were no differences in ACS between patients with or without COVID-19. Ultimately, there were no differences in stroke or HFH (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>B).<elsevierMultimedia ident="fig0005"></elsevierMultimedia>At 6-month follow-up, we found a higher risk of all-cause death in COVID-19 patients. However, the difference between the groups was driven by a higher in-hospital all-cause death risk, without an increased risk during the post-discharge follow-up. Our data suggest that COVID-19 infection could be related to adverse acute cardiovascular outcomes without impaired outcomes beyond the disease's acute phase. Larger registries with extended follow-up must be performed to determine the long-term effect of COVID-19 on the cardiovascular system.FundingThis study has been funded by Carlos III Institute, Madrid, Spain [Research grant COV20/00040]." "textoCompletoSecciones" => array:1 [ "secciones" => array:2 [ 0 => array:2 [ "identificador" => "sec0005" "titulo" => "Funding" ] 1 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "NotaPie" => array:1 [ 0 => array:3 [ "etiqueta" => "1" "nota" => "Both authors equally contributed to this paper." "identificador" => "fn1" ] ] "multimedia" => array:1 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2258 "Ancho" => 1500 "Tamanyo" => 179042 ] ] "descripcion" => array:1 [ "en" => "All-cause death and cardiovascular outcomes at six months follow-up in patients with or without COVID-19. (A) All-cause death time-to-event curve. (B) Six months follow-up cardiovascular outcomes. ACS, acute coronary syndrome; CV, cardiovascular; HFH, heart failure hospitalization; PE, pulmonary embolism." ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:5 [ 0 => array:3 [ "identificador" => "bib0030" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "COVID-19 and the cardiovascular system" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "Y.Y. Zheng" 1 => "Y.T. Ma" 2 => "J.Y. Zhang" 3 => "X. Xie" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/s41569-020-0360-5" "Revista" => array:7 [ "tituloSerie" => "Nat Rev Cardiol" "fecha" => "2020" "volumen" => "17" "paginaInicial" => "259" "paginaFinal" => "260" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32139904" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S014067360860269X" "estado" => "S300" "issn" => "01406736" ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0035" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S. Shi" 1 => "M. Qin" 2 => "B. Shen" 3 => "Y. Cai" 4 => "T. Liu" 5 => "F. Yang" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/jamacardio.2020.0950" "Revista" => array:6 [ "tituloSerie" => "JAMA Cardiol" "fecha" => "2020" "volumen" => "5" "paginaInicial" => "802" "paginaFinal" => "810" "itemHostRev" => array:3 [ "pii" => "S0889855309000107" "estado" => "S300" "issn" => "08898553" ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0040" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Elevated troponin in patients with coronavirus disease 2019: possible mechanisms" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "G. Tersalvi" 1 => "M. Vicenzi" 2 => "D. Calabretta" 3 => "L. Biasco" 4 => "G. Pedrazzini" 5 => "D. Winterton" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.cardfail.2020.04.009" "Revista" => array:6 [ "tituloSerie" => "J Card Fail" "fecha" => "2020" "volumen" => "26" "paginaInicial" => "470" "paginaFinal" => "475" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32315733" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0045" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Coronavirus disease 2019 – associated thrombosis and coagulopathy: review of the pathophysiological characteristics and implications for antithrombotic management" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "L. Ortega-Paz" 1 => "D. Capodanno" 2 => "G. Montalescot" 3 => "D.J. Angiolillo" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1161/JAHA.120.019650" "Revista" => array:5 [ "tituloSerie" => "J Am Heart Assoc" "fecha" => "2021" "volumen" => "10" "paginaInicial" => "1" "paginaFinal" => "24" ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0050" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Standardized end point definitions for coronary intervention trials: the academic research consortium-2 consensus document" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "H.M. Garcia-Garcia" 1 => "E. McFadden" 2 => "A. Farb" 3 => "R. Mehran" 4 => "G.W. Stone" 5 => "J. Spertus" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1161/CIRCULATIONAHA.117.029289" "Revista" => array:6 [ "tituloSerie" => "Circulation" "fecha" => "2018" "volumen" => "137" "paginaInicial" => "2635" "paginaFinal" => "2650" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29891620" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/23870206/0000015800000001/v2_202201200752/S2387020621006720/v2_202201200752/en/main.assets" "Apartado" => array:4 [ "identificador" => "43309" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Letters to the Editor" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/23870206/0000015800000001/v2_202201200752/S2387020621006720/v2_202201200752/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020621006720?idApp=UINPBA00004N"]

ISSN: 2387-0206

Launched in 1943, Medicina Clínica is a fortnightly journal aimed at the promotion of clinical research and practice among internal medicine and other specialists. The key characteristics of Medicina Clínica are the scientific and methodological rigor of its manuscripts, the topicality of its contents, and, especially, its practical focus with highly useful information for clinical practice. Medicina Clínica is predominantly interested in publishing original research manuscripts, which are rigorously selected according to their quality, originality, and interest, and also in continued medical education-oriented manuscripts, which are commissioned by the journal to relevant authors (Editorials, Reviews, and Diagnosis and Treatment). These manuscripts contain updated topics with a major clinical or conceptual relevance in modern medicine. The journal adheres to the standards of academic research publications in all aspects including peer-review and ethical principles. Medicina Clínica is included in the General and Internal Medicine category of Thomson Reuters.

See more Open Access Option

Indexed in:

Current Contents/Clinical Medicine, Journal Citation Reports, SCI-Expanded, Index Medicus/Medline, Excerpta Medica/EMBASE, IBECS, IME, MEDES, PASCAL, SCOPUS, SciVerse ScienceDirect

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2023

2.6

Citescore

CiteScore measures average citations received per document published.

Citescore 2023

3.1

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2023

0.371

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2023

0.511

View more metrics

Journal Information

Previous article | Next article

Vol. 158. Issue 1.